Researchers at Purdue University have developed a new type of cancer therapy that uses a modified microRNA, miR-34a, to block cancer cell division. In preclinical tests in mice, treatment using the ...
A new cancer therapy developed by Purdue University researchers attacks tumors by tricking cancer cells into absorbing a snippet of RNA that naturally blocks cell division. As reported Monday (Sept. 4 ...
WEST LAFAYETTE — A new cancer therapy developed by Purdue University researchers attacks tumors by tricking cancer cells into absorbing a snippet of RNA that naturally blocks cell division. As ...
COLUMBUS, Ohio, April 02, 2026--(BUSINESS WIRE)--Armatus Bio, a late-preclinical stage biotech innovator developing vectorized RNAi medicines in neuromuscular disorders, today announced the ...
To explore the pan-cancer expression pattern of miR-668-3p, we retrieved the TCGA (Pan-Cancer) dataset from the UCSC Xena database (https://xenabrowser.net ...
New research by Lupus Foundation of America Gina M. Finzi Memorial Fellowship Awardee Kristen Bricker reveals new clues about lupus disease development and possible future treatment approaches. Her ...
A new therapy for cancer uses microRNA to slow or stop division of cancer cells. (Photo provided by Second Bay Studios) WEST LAFAYETTE, Ind. – A new cancer therapy developed by Purdue University ...
A new cancer therapy attacks tumors by tricking cancer cells into absorbing a snippet of RNA that naturally blocks cell division. A new cancer therapy developed by Purdue University researchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results